Literature DB >> 9509115

The response of adenoid cystic carcinoma to tamoxifen.

A Shadaba1, M N Gaze, H R Grant.   

Abstract

Adenoid cystic carcinoma of the parotid gland often recurs locally, or metastases develop, after initial treatment with surgery and radiotherapy. We report a patient with an inoperable local recurrence of previously irradiated adenoid cystic carcinoma, who was treated with tamoxifen, an oestrogen receptor antagonist. After 18 months of treatment with tamoxifen, MRI showed a partial response, and further clinical progression of the disease was halted.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9509115     DOI: 10.1017/s0022215100139684

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  10 in total

1.  Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma.

Authors:  Min Li; Bing-Rong Zhao; Shi-Qing Liu; Jian An; Peng-Bo Deng; Han Han-Zhang; Jun-Yi Ye; Xin-Ru Mao; Shao-Kun Chuai; Cheng-Ping Hu
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

2.  Salivary gland cancers: biology and molecular targets for therapy.

Authors:  Diana Bell; Ehab Y Hanna
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

Review 3.  [Salivary gland carcinomas Part II. Diagnosis and therapy].

Authors:  S Lang; N Rotter; A Lorenzen; S Ihrler; R Eckel; D Hölzel; G Rasp; B Wollenberg; K Sommer
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

4.  Mutational landscape of lacrimal gland carcinomas and implications for treatment.

Authors:  Diana Bell; Matthew C Sniegowski; Khalida Wani; Victor Prieto; Bita Esmaeli
Journal:  Head Neck       Date:  2015-06-15       Impact factor: 3.147

5.  Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases.

Authors:  Adam D Elkin; Charlotte D Jacobs
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-18       Impact factor: 4.553

Review 6.  Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved.

Authors:  Markus Stenner; J Peter Klussmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-04       Impact factor: 2.503

Review 7.  Systemic therapy in the management of metastatic or advanced salivary gland cancers.

Authors:  Aymen Lagha; Nesrine Chraiet; Mouna Ayadi; Sarra Krimi; Bassem Allani; Hela Rifi; Henda Raies; Amel Mezlini
Journal:  Head Neck Oncol       Date:  2012-05-04

8.  Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.

Authors:  Ryuichi Murase; Tomoki Sumida; Akiko Ishikawa; Rumi Murase; Sean D McAllister; Hiroyuki Hamakawa; Pierre-Yves Desprez
Journal:  Int J Otolaryngol       Date:  2011-11-21

9.  Multicentre clinicopathological study of adenoid cystic carcinoma: A report of 296 cases.

Authors:  Zheng Huang; Juan Pan; Jiaorong Chen; Shidi Wu; Ting Wu; Haihua Ye; Hongfeng Zhang; Xiu Nie; Changzheng Huang
Journal:  Cancer Med       Date:  2021-01-15       Impact factor: 4.452

10.  Case report: anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland.

Authors:  Saúl Campos-Gómez; Jose H Flores-Arredondo; Rita Dorantes-Heredia; Mónica Chapa-Ibargüengoitia; Roberto de la Peña-Lopez
Journal:  BMC Cancer       Date:  2014-09-23       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.